Evaluating the Impact of Linezolid Metabolites: PNU‐142300 and PNU‐142586 on the Development of Linezolid‐Induced Thrombocytopenia in Adult Patients

Documenti analoghi

• Development of a Risk Prediction Model for Linezolid‐Induced Thrombocytopenia Based on the Machine Learning Algorithm
  di: Jie Chi, et al.
  Pubblicazione: (2025)
• Optimizing Linezolid Dosing in Lung Transplant Recipients: Population Pharmacokinetics, Target Attainment, and Thrombocytopenia Risk Assessment
  di: Dan Zhang, et al.
  Pubblicazione: (2026)
• Linezolid‐induced lactic acidosis in critically ill patients: A multicentre study of incidence, severity and predictors
  di: Lina Naseralallah, et al.
  Pubblicazione: (2026)
• Pharmacokinetics and Safety of Linezolid Tablets of 2 Different Manufacturers in Healthy Chinese Subjects in Fasting and Fed States
  di: Hanjing Chen, et al.
  Pubblicazione: (2024)
• Predictive Modeling of Drug‐Related Adverse Events with Real‐World Data: A Case Study of Linezolid Hematologic Outcomes
  di: Anu Patel, et al.
  Pubblicazione: (2024)